Cytokines and depression

International Review of Neurobiology

Volumn 52, Issue , 2002, Pages 255-273

  Clow, Angela ^a  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ANIMAL; DEPRESSION; HUMAN; IMMUNOLOGY; NEUROSECRETION; PHYSIOLOGY; PSYCHOPHYSIOLOGY; REVIEW;

ANIMALS; CYTOKINES; DEPRESSION; HUMANS; NEUROSECRETORY SYSTEMS; PSYCHONEUROIMMUNOLOGY;

EID: 0036364404     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(02)52012-2     Document Type: Review

References (91)

1. Arborelius, L., Owens, M. J., Plotsky, P. M., and Nemeroff, C. B. (1999). The role of corticotrophin-releasing factor in depression and anxiety disorders. J. Endocrinol. 160, 1-12.
2. Ban, T. A. (2001). Pharmacotherapy of depression: A historical analysis. J. Neural. Transm. 108, 707-716.
3. Barden, N. (1996). Modulation of glucocorticoid receptor gene expression by anlidepressanl drugs. Pharmacopsychiatry 29, 12-22.
4. Besedovsky, H., Del Rey, A., and Sorkin, E. (1983). The immune response evokes changes in brain noradrenergic neurones. Science 221, 564-566.
5. Besodovsky, H. O., Del Rey, A., Klusman, I., Furukawa, H., Monge Arditi, G., and Kabiersch, A. (1991). Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J. Steroid Biochem. Mol. Biol 40, 613-618.
6. Bottiglieri, T., Hyland, K., Laundy, M., Godfrey, P., Carney, M. W., Toone, B. K., and Reynolds, E. H. (1992). Folate deficiency, bioptcrin and monoamine metabolism in depression. Psychol. Med. 22, 871-876.
7. Bradbury, M.J., Akana, S. F., Casrio, C. S., Levin, N., Jacobson, L., and Dallman, M. F. (1991). Regulation of basal ACTH secretion by corticosterone is mediated by both type 1 (MR) and type 2 (glucocorticoid receptor) receptors in rat brain. J Steroid Biochem. Mol. Biol. 40, 105-111.
8. Brown, E. S., and Suppcs, T. (1998). Mood symptoms during corticosteroid therapy: A review. Harvard Rev. Psychiatry 5, 239-246.
9. Bunnev, W. F.., and Fawcett, J. A. (1965). Possibility of a biochemical test for suicidal potential. Arch. Gen. Psychiatry 13, 232-239.
10. Cappel, R., Gregiore, F, Thiry, L., and Sprecher, S. (1978). Antibody and cell-mediated immunity to herpes simplex virus in psychotic depression. J. Clin. Psychiatry 39, 266-268.
11. Capuron, L., Ravaud, A., Guald, N., Bosnians, E., Dantzer, R., Maes, M., and Neveu, J. (2001). Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 26, 797-808.
12. Carroll, B. J., Curtis, G. C., Davies, B. M., Mendels, J., and Sugarman, A. A. (1976). Urinary free cortisol excretion in depression. Psychol. Med. 6, 43-40.
13. Carroll, B. J., Feinbcrg, M., Greden, J. F., Tarika, J., Albala, A. A., Basket, R. F., James, N. M., Kronfol, Z., Lohr, N., Steiner, M., de Vigne, M. P., and Young, E. (1981). A specific laboratory test for the diagnosis of melancholia: Standardization, validation and clinical utility. Arch. Gen. Psychiatry 38, 15-22.
14. Castanon, N., Bluthe, R. M. and Danlzcr, R. (2001). Chronic treatment with the atypical antidcpressant tianeptine attenuates sickness behaviour induced by peripheral but not central lipopolvsaccharide and interleukin-1β in the rat. Psychopharmacology 154(1), 50-60.
15. Cohen, P., Pine, D. S., Must, A., Rasen, S., and Brook, J. (1998). Prospective associations between somatic illness and mental illness from childhood to adulthood. Am. J. Epidemiol. 147, 232-239.
16. Connor, T. J., and Leonard, B. E. (1998). Depression, stress and immunological activation: The role of cytokines in depressive disorders. Life Sri 62, 583-600.
17. Coppen, A., Swade, C, Jones, S. A., Armstrong, R. A., Blair, J. A., and Leeming, R. J. (1989). Depression and tetrahydrobiopterin: The folate connection. J. Affect. Disord. 16, 103-107.
18. Danzer, R. (1999). Sickness behaviour: A neuroimmune-bascd response to infections, in “Psv-choncuroimmunology: An Interdisciplinary Introduction” (M. Schedlowski, and U. Tewes. eds.), Kluwer Academic/Plenum, New York.
19. Dickens, C., McGowan, I.., Clark-Oartcr, D., and Creed, F. (2002). Depression in rheumatoid arthritis: A systematic review of the literature with meta-analysis. Psychosom. Med. 65, 52-60.
20. Dinan, T. G. (1994). Glucocorticoids and the genesis of depressive illness: A psychobiological model. Br. J. Psychiatry 164, 365-371.
21. Diorio D., Viau, V., and Meaney, M. J. (1993). The role of the medial prefrontal cortex (cin-gulatcd gyrus) in the regulation of the hypotbalamic-pituitarv-adrenal responses to stress. f. Neurosci. 13, 3839-3847.
22. Dunbar, P. R., Hill, J., Neale, T. J., and Mellsop, G. W. (1992). Neopterin measurement provides evidence ol altered cell-mediated immunity in patients with depression, but not with schizophrenia. Psychol. Med. 22, 1051-1057.
23. Evans, D. L., Burnett, G. B., and Nemeroff, C. B. (1983). The dcxamethasone suppression test in the clinical setting. Am. J. Psychiatry 140, 586-589.
24. Feldman, S., and Weidenleld, J. (1999). Glucocorticoid receptor antagonists in the hippoc ampus modify the negative feedback following neural stimuli. Brain Res. 821, 33-37.
25. Ferrini, M., Piroli, G., Frontcra, M., Falbo, A., Lima, A., and De Nicola, A. F. (1999). Estrogens normalize the hypothalanric-pituitary-adrenal axis in response to stress and increase glucocorticoid receptor immunoreactivity in hippocampus of aging male rats. Neuroendoninology 69,129-137.
26. Frank, M. G., Hendricks, S. E., Johnson D. R., Wieseler, J. L., and Burke, W. J. (1999). Antidepressants augment natural killer cell activity: In two and in vitro. Neuropsychobiology 39, 18-24.
27. Heuser, I.(1998). The hypothalamic-pituitary-adrenal system in depression. Pharmacopsychiatry 31,10-13.
28. Irwin, M., and Gillin, J. C. (1987). Impaired natural killer cell activity among depression patients. Psychiatry lies 20, 181-182.
29. Irwin, M., Smith, F. L., and Gillin, J. C. (1987). Low natural killer cell cvtotoxicily in major depression. Life Sci. 41, 2127-2133.
30. Jain, R., Zwicker, D., Hollander, C. S., Brand, H., Saperstein, A., Hutchinson, B., Brown, C... and Audhva, T. (1991). Corticotrophin-releasing factor modulates the immune response to stress in rats. Endocrinology 128, 1329-1336.
31. Jeffcoate, W. J., Silverstone, J. T., Edwards, C R., and Besser, G. M. (1979). Psvchiatric manifestations of Cushing’s Syndrome: Response to lowering plasma cortisol. Q J. Med. 191, 465-472.
32. Joyce, P., Hawes, C., Mulder, R., Sellman J., Wilson, D., and Boswell, D, (1992). Elevated levels of acute phase proteins in major depression. Biol. Psychiatry 32, 1035-1041.
33. Kent, S., Bluthe, R. M., Kelley, K. W., and Dantzer, R. (1992). Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 13, 24-28.
34. Kiecolt-Glaser, J. K., McGuire, L., Robles, T. F., and Glaser, R. (2002)-Emotions, morbidity, and mortality: New perspectives in psychoneuroimmunology. Annu. Rev. Psychol. 53, 83-107.
35. Kockler, M., and Heim, R. (2002). Gender differences of depressive symptoms in depressed and nondepressed elderly persons. Int.J. Geriatr. Psychiatry 17, 65-72.
36. Krishnan, K. R., Doraiswamy, R M., Lurie, S. N., Figiel, G. S., Husain, M. M., Boyko, O. B., Ellinwood, E. H., and Nemerof, C. B. (1991). Pituitary size in depression. J. Clin. Endocrinol. Metab. 72(2), 256-259.
37. Kronfol, Z., and House, J. D. (1985). Depression, hypothalamic-pituitar adrenocortical activity, and lymphocyte function. Psychopharmacol Bull. 21(3), 476-478.
38. Kronfol, Z., Silva, J., Greden, J., Dembinsky, S., Gardener, R., and Carroll, B. (1983). Impaired lymphocyte function in depressive illness. Life Sci. 33, 241-247.
39. Kvetnansky, R., Fukuhara, K., Pacak, K., Cizza, G., Goldstein, D. S., and Kopin, I. J. (1993). Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilisation stress in rats. Endocrinology 133, 1411-1419.
40. Lippman, M., and Barr, R. (1977). Glucocorticoid receptors in purified subpopulations of human peripheral blood lymphocytes. J. Immunol. 118, 1977-1981.
41. Lowry, M. T., Reder, A. T., Antel, J. P., and Meltzer, H. Y (1984). Glucocorticoid resistance in depression: The dexamethasone suppression test and lymphocyte sensitivity to dexamethasone. Am.J. Psychiatry 141, 1365-1370.
42. Maes, M., Bosnians, E., Suy, E., Vandervorst, C., Dejonckheere, C., Minner, B., and Raus, J. (1991). Depression-related disturbances in mitogen-induced lymphocyte responses, interleukin-1β and soluble interIeukin-2-receplor production. Ada Psychiatr. Scand. 84, 379-386.
43. Maes, M., Stephems, W., DeClerck, L., Bridts, C., Peeters, D., Schotte, C., andCosyns, P. (1992a). Immune disorders in depression: Higher T Helper/T Suppressor-cytotoxic cell ratio. Acta Psychiatr Scand. 86, 423-431.
44. Maes, M., Van der Planken, M., Stephens, W., Peeters, D., DeClerck, L., Bridts, C., Schotte, C., and Cosyns, P. (1992b). Leukocytosis, monocytosis and neutrophilia: Hallmarks of severe depression. J. Psychiatr Res. 26(2), 125-134.
45. Maes, M., Stephens, W., DeClerck, L., Bridts, C., Peeters, D., Schotte, C., and Cosyns, P. (1993). Significantly increased expression of T-cell activation markers (interleukin 2 and HLA-DR) in depression. Further evidence for an inflammatory process during illness. Pog. Neuropsy-chopharmacol. Biol. Psychiatry 17, 241-255.
46. Maes, M., Scharpe, S., Van Grootel, L., Uyttenbroeck, W., Cooreman, W., Cosyns, P., and Suv, E. (1994). Increased neopterin and interferon-γ secretion and lower availability of L-tryptophan in major depression: Further evidence for an immune response. J. Psychiatr. Res. 54, 143-160.
47. Maes, M., Meltzer, H., Buckley, P., and Bosnians, E. (1995). Plasma soluble interleukin-2 and transferring receptor in schizophrenia and major depression. Arch. Psychiatr. Clin. Neurosci. 244(6), 325-329.
48. Maes, M., Wauters, A., Verkerk, R., Demedts, P., Neels, H., van Gastcl, A., Cosyns, P., Scharpe, S., and Desnyder, R. (1996). Lower serum tryptophan availability in depression as a marker of a more generalized disorder in protein metabolism. Neuropsychopharmacology 15, 243251.
49. Maes, M., Verkerk, R., Vandoolaeghe, E., Van Hunsel, F., Neels, H., Wauters, A., Demedts, P., and Scharpe, S. (1997). Serotonin-immune interactions in major depression: Lower serum tryptophan as a marker of an immune-inflammatory response. Eur. Arch. Psychiatry Clin. Neurosci. 247, 154-161.
50. Maes, M., Bonaccorso, S., Marino, V., Puzella, A., Pasquini, M., Biondi, M., Artini, M., Almerighi, C., and Meltzer, H. (2001). Treatment with interferon-α (INF-α) of hepatitis C patients induces lower dipeptidyl peptidase IV activity, which is related to INF-α-induced depressive and anxiety symptoms and immune activation. Mol. Psychiatry 6(4) 475-480.
51. Magarinos, A. M., Somoza, G., and De Nicola, A. F. (1987). Glucocorticoid negative feedback and glucocorticoid receptors after hippocampectomy in rats. Harm. Metab. Res. 19, 105109.
52. Maier, S. F., and Watkins, L. R. (1998). Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood and cognition. Psychol Rev. 105, 83-107.
53. Mendlovic, S., Mozes, E., Eilat, E., Doron, A., Lereya, J., Zakuth, V, and Spirer, Z. (1999). Immune activation in non-treated suicidal major depression. Immunol. Lett. 67, 105-108.
54. Miller, A. H. (1998). Neuroendocrine and immune system interactions in stress and depression. Psychoneuroendocrinology 21, 443-463.
55. Miller, A. H., Spenser, R. L., Pulera, M., Kang, S., McEwan, B. S., and Stein, M. (1992). Adrenal steroid receptor activation in rat brain and pituitary following dexamethasone: Implications for dexamesathone suppression test. Biol. Psychiatry 32, 850-869.
56. Mizoguchi, K., Yuzurihara, M., Ishige, A., Sasaki, H., Chui, D.-H., andTabira, T. (2001). Chronic stress differentially regulates glucocorticoid negative feedback response in rats. Psychoneuroendocrinology 26, 443-459.
57. Modell, S., Yassouridis, A., Huber, J., and Holsboer, F. (1997). Corticosteroid receptor function is decreased in depressed patients. Neuroendocrinology 65, 216-222.
58. Murphy, B. E. P. (1991). Steroids and depression. J Steroid Biochem,. Mol. Biol. 38, 537-559.
59. Nassberger, L., and Traskman-Bendz, L. (1993). Increased soluble interleukin-2 receptor in suicide attempters. Acta Psychiatr. Scand. 88, 48-52.
60. Nemeroff, C. B. (1988). The role of corticotrophin-releasing factor in the pathogenesis of major depression. Pharmacopsychiatry 21, 76-82.
61. Nemeroff, C. B., Widerlov, E., Bisset, G., Walleus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., and Vale, W. (1984). Elevated concentrations of corticotrophin-releasing factor-like immunoreactivity in depressed patients. Science 22G, 1342-1344.
62. Nemeroff, C. B., Bissette, G., Akil, H., and Fink, M. (1991). Neuropeptide concentrations in the CSF of depressed patients treated with elcctroconvulsive shock therapy. Corticotrophin-releasing factor, β-endorphin and somatostatin. Br. J. Psychiatry 158, 59-63.
63. Nemeroff, C. B., Krishnan, K. R., Reed, D., Leder, R., Beam, C., and Dunnick, N. R. (1992). Adrenal gland enlargement in major depression. A computed tomographic study. Arch. Gen. Psychiatry 49(5), 384-387.
64. Okuhara, D. Y, and Beck, S. G. (1998). Corticosteroids alter 5-hydroxytryptamineiA receptor-effector pathway in hippocampal subfield CA3 pyramidal cells. J Pharmacol Exp. Ther. 284, 1227-1233.
65. Owens, M. J., and Nemeroff, C. B. (1991). Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 43, 425-473.
66. Pacak, K., Palkovits, M., Kvetnansky, R., Matern, P., Hart, C., Kopinm, I. J., and Goldstein, D. S. (1995). Catecholaminergic inhibition by hypercortisolemia in the PVN nucleus of the c onscious rat. Endocrinology 136, 4814-4819.
67. Pariante, C. M., Nemeroff, C. B., and Miller, A. H. (1995). Glucocorticoid receptors in depression. Isr. J. Med. Sci. 31, 705-712.
68. Peiffer, A., Veilleux, S., and Barden, N. (1991). Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain. Psychoneuroendocrinology 16, 505-515.
69. Pepin, M. C., Beaulieu, S., and Barden, N. (1989). Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures. Mol. Brain Res. 6, 77-83.
70. Raison, C. L., and Miller, A. H. (2001). The neurobiology of stress and depression. Semin. Clin. Neuropsychiatry 6, 277-295.
71. Ravindran, A. V., Griffiths, J., Merali, Z., Knott, V. J., and Anisman, H. (1999). Influences of acute tryptophan depletion on mood and immune measure in healthy males. Psychoneuroendocrinology 24, 99-113.
72. Ritchie, J. C., and Nemeroff, G. B. (1991). Stress, the hypothalamic-pituitary-adrcnal axis and depression. In ‘‘Stress, Neuropeptides and Systemic Disease”. Academic Press, San Diego.
73. Rohleder, N., Schomer, N. G., Hellhammer, D. H., Engel, R., and Kirschbaum, C. (2001). Sex differences in glucocorticoid sensitivity of proinflammatory cytokine production after psychosocial stress. Psychosom. Med. 63, 966-972.
74. Rosmond, R., Dallman, M. F., and Bjorntorp, P. (1998). Stress-related cortisol secretion in men: Relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J. Clin. Endocrinol. Metab. 83, 1853-1859.
75. Rubin, R. T., Phillips, J. J., Sadow, T. F., and McCracken, J. T. (1995). Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment. Arch. Gen. Psychiatry 52(3), 213-218.
76. Sapolsky, R. M., Kiev, L. C., and McEwan, B. S. (1984). Stress downregulates corticosterone receptors in a site-specific manner in the brain. Endocrinology 114, 287-292.
77. Shekelle, R. B., Raynor, W. J., Ostfield, A. M., Garron, D. C., Bieliauskas, L. A., Liu, S. C., Malila, C., and Paul, O. (1981). Psychological depression and 17-ycar risk of death from cancer. Psychosomat. Med. 43, 117-125.
78. Shuto, H., Kataoka, Y, Horikawa, T., Fujihara, N., and Oishi, R. (1997). Repeated interferon-a administration inhibits dopaminergic neural activity in the mouse brain. Brain Res. 747, 348-351.
79. Spencer, R. L., Miller, A. H., Stein, M., and Mc Fwen, B. S. (1991). Corticosterone regulation of type I and type II adrenal steroid receptors in brain, pituitary, and immune tissue. Brain Res. 549, 236-246.
80. Starkman, M. N., and Schteingart, D. E. (1981). Neuropsychiatric manifestations of patients with Cushing’s syndrome. Arch. Intern. Med. 141, 215-219.
81. Stein, M., Miller, A. II., and Trestman, R. L. (1991). Depression and the immune system. In “Psychoneuroimmunology’' 2nd ed. (Robert Ader, David L. Felter, and Nicholas Cohen, eds.), pp. 897-930. Academic Press, New York.
82. Sternberg, E. M. (1997). Emotions and disease: From balance of humours to balance of molecules. Nat. A led. 3, 264-267.
83. Sunanda Rao, B. S., and Raju, T. R. (2000). Restraint stress-induced alterations in the levels of biogenic amines, amino acids, and AChE activity in the hippocampus. Neurochem. Res. 25, 1547-1552.
84. Tondo, L., Pani, P. P., Pcllegrini-Bettoli, R., Milia, G., and Manconi, P. E. (1988). T-Lymphocytes in depressive disorder. Med. Sci. Res. 16, 867-868.
85. Torpy, D. J., and Chrousos, G. P. (1996). The three-way interactions between the hypothalamic-pituitary-adrenal and gonadal axes and the immune system. Baillieres Clin. Rheumatol. 10, 181-198.
86. Trimble, M. R. (1998). “Biological Psychiatry,” pp. 241-281. Wiley, Chichester.
87. van Amsterdam, J. G., and Opperhuizen, A. (1999). Nitric oxide and biopterin in depression and stress. Psychiatry Res. 18, 33-38.
88. Van West, D., and Maes, M. (1999). Activation of the inflammatory response system: A new look at the etiopathogenesis of depression. Neuroendocrinol. Lett. 20(1-2), 11-17.
89. Weber, B., Lewicka, S., Deuschle, M., Colla, M., Vecsei, P., and Heuser, I. (2000). Increased diurnal plasma concentrations of cortisone in depressed patients. J. Clin. Endrocrin. Metab. 85,1133-1136.
90. Zeiger, M. A., Franker, D. L., Pass, H. I., Nieman, L. K., Cutler, G. B., Chrousos, G. P., and Norton, J. A. (1993). Effective reversibility of the signs and symptoms of hypercortisolism by bilateral adrenalectomy. Surgery 114, 1138-1143.
91. Zorrilla, E. P., Luborskv, L., McKay, J. R., Rosenthal, R., Houldin, A., Tax, A., McCorkle, R., Seligman, D. A., and Schmidt, K. (2001).. The relationship of depression and stressors to immunological assays: A meta-analytic review. Brain Behav. Immun. 15, 199-226.